Saturday, May 18, 2024

1 in 3 Covaxin recipients hit by adverse events: Study

Thursday, May 16, 2024, 19:28
This news item was posted in Buzz category and has 0 Comments so far.

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual abnormalities in 5% of women. AstraZeneca’s vaccine technology controversy and Covishield’s development by the Serum Institute of India are notable. The study reported viral upper respiratory tract infections in adolescents and adults.

You can leave a response, or trackback from your own site.

Leave a Reply